AstraZeneca Sues Mylan Over Crestor Patent
AstraZeneca Pharmaceuticals LP has filed another patent infringement suit against Mylan Pharmaceuticals Inc. alleging infringement of a patent for its cholesterol drug Crestor, just two weeks after firing off similar suits...To view the full article, register now.
Already a subscriber? Click here to view full article